Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
New York, United States · Founded 2019 · $126.0M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- gilgameshpharmaceutical.com
- Total Funding
- $126.0M
- Last Round
- $60.0M Series AMar 2026
- Rounds
- 3
About
Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.
Summary
Gilgamesh Pharmaceuticals is a Healthcare company based in New York, United States, founded in 2019. It has raised $126.0M in total across 3 rounds, most recently a $60.0M Series A round in Mar 2026.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Telehealth platform providing personalized health and wellness treatments for men and women, cove...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
COMPASS Pathways is dedicated to accelerating patient access to evidence-based innovation in ment...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...